Post-1962 generics
Executive Summary
FDA has approved approximately 150 ANDAs for post-1962 generic drugs out of approximately 1,250 ANDAs (including applications for different dosage forms and strengths) submitted to the agency since the ANDA/patent restoration law became effective, FDA Commissioner Young recently told the House Health & Environment Subcommittee. He said the agency has approved approximately 1,450 generics of pre-1962 drugs.
You may also be interested in...
DJO Thinks Trilliant Is Brilliant, Announces Acquisition
DJO Global will buy Trilliant Surgical to further its ongoing expansion into the US foot and ankle market.
Legend Biotech CEO Ying Huang On Moving Fast In the BCMA CAR-T Race
Ying Huang was named CEO as his predecessor came under investigation in China and as partner Janssen was getting closer to seeking US FDA approval for its lead CAR-T therapy.
Brazil Authorizes Oxford/AZ and Sinovac Vaccines
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: